Transatlantique Private Wealth’s Pfizer PFE Stock Holding History

Transatlantique Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,137	Closed	-$648K	–	225
2024 Q2	$648K	Buy	23,137 +554	+2%	+$15.3K	0.26%	112
2024 Q1	$627K	Buy	22,583 +11,214	+99%	+$311K	0.27%	126
2023 Q4	$327K	Sell	11,369 -15,243	-57%	-$461K	0.15%	176
2023 Q3	$883K	Buy	26,612 +63	+0.2%	+$2.23K	0.47%	72
2023 Q2	$974K	Buy	26,549 +519	+2%	+$20.2K	0.51%	64
2023 Q1	$1.06M	Sell	26,030 -5,116	-16%	-$221K	0.59%	50
2022 Q4	$1.6M	Buy	31,146 +333	+1%	+$16K	0.96%	24
2022 Q3	$1.35M	Buy	30,813 +2,113	+7%	+$103K	0.9%	26
2022 Q2	$1.5M	Buy	+28,700	New	+$1.46M	1.05%	18

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Transatlantique Private Wealth's PFE Position: Q3 2024 in Review

Transatlantique Private Wealth sold out of Pfizer (PFE) in Q3 2024, closing a stake of 23,137 shares — an estimated $648K sold.

Transatlantique Private Wealth first reported a position in PFE in Q2 2022 and held it in 9 quarters. The position peaked at $1.6M in Q4 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Transatlantique Private Wealth reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Transatlantique Private Wealth sold 23,137 Pfizer shares in Q3 2024, an estimated $648K.
Transatlantique Private Wealth first reported a position in Pfizer in Q2 2022 and held it in 9 quarters.
Transatlantique Private Wealth's Pfizer position peaked at $1.6M in Q4 2022.
2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Transatlantique Private Wealth's 13F filing for Q3 2024, filed 13 Nov 2024.